CSIMarket
 


Icad Inc  (ICAD)
Other Ticker:  
 


Icad Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Icad Inc's ROI in the third quarter of 2023?
Icad Inc recorded a cumulative net loss of $-10 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -28.51%.

Within the Healthcare sector 402 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2023 quarter, so far to 3546, from total ROI ranking in the second quarter of 2023 at 3757.

Definition and Formula of Return on Investment


Return On Investment (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Investment Change -15.59 % -25.43 % -21.96 % -19.01 % -
Y / Y Net Income Change - - - - -
Investment (TTM) in Millions 34 33 35 38 41
Return On Investment (TTM) -28.51 % -34.16 % -35.2 % -32.6 % -33.32 %
ICAD's Overall Ranking # 3546 # 3757 # 3890 # 4076 # 0
Seq. Investment Change 4.48 % -4.9 % -9.45 % -6.18 % -7.7 %
Seq. Net Income Change - - - - -
Net Income (TTM) in Millions -10 -13 -14 -14 -15




Return On Investment ICAD's Ranking
Within: No.
Industry # 115
Sector # 403
Overall # 3546

Return On Investment Statistics
High Average Low
-1.69 %
-44.94 %
-95.16 %
(Dec. 30, 2014)   (March 31, 2016)



  News about Icad Inc

iCAD Expands Sales Leadership Team and Adds Key Executives to Accelerate Growth Amidst New Products and Partnerships



As iCAD Inc, a leading healthcare technology company, continues to expand its business and enhance its product offerings, it has made important additions to its executive sales leadership team. Bill Keyes, an existing member of the team, has transitioned to the role of Senior Vice President, Global Sales Operations. Additionally, Peter Graham has joined iCAD as the new Senior Vice President, North American Sales. These strategic appointments aim to accelerate the company's growth and further establish its presence in the healthcare sector.
Expansion of Roles:
Bill Keyes, previously serving in a different capacity within the executive sales leadership team, has assumed the crucial role of Senior Vice President, Global Sales Operations. In this newly expanded position, Keyes will play a key role in overseeing iCAD's sales operations on a global scale. With his extensive experience and deep understanding of the company's operations, Keyes is expected to contribute significantly to iCAD's growth strategy.






Financial Statements
Icad Inc's III. Quarter Investments $ 34 Millions ICAD's Balance sheet
Icad Inc's III. Quarter Income $ -1 Millions Quarterly ICAD's Income Statement
ICAD's Income by Division See ICAD's Income by Division


ICAD Annual Return On Investment (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Investments in Millions 38 47 39 9 12
Y / Y Investment Growth -19.01 % 21.63 % 318.89 % -19.55 % -42.57 %
Net Income in Millions -14 -11 -18 -14 -9
Y / Y Net Income Growth - - - - -
Annual Return On Investment -35.7 % -23.81 % -45.35 % -146.18 % -78.26 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ICAD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for ICAD's Competitors
Roi for Icad Inc's Suppliers
Return On Investment for ICAD's Customers

Other Ratios
ICAD's Roa ICAD's Inventory Turnover Ratio ICAD's Growth Rates ICAD's Dividend Statistics
ICAD's Profitability Ratios ICAD's Asset Turnover Ratio ICAD's Dividend Growth
ICAD's Roe ICAD's Valuation Ratios ICAD's Financial Strength Ratios ICAD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI


Date modified: 2023-11-16T14:05:20+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com